Mitsubishi Chemical Complete New Production Facility for Aluminum Composite Materials

Mitsubishi Chemical Functional Products, Inc. announces that its subsidiary in the United States - Mitsubishi Chemical FP America has completed its new production line for the manufacture of ALPOLIC®/fr, the company’s fire-rated Aluminum Composite Material (ACM) with a noncombustible mineral core. With the increased popularity of fire-rated grade panels because of stricter fire regulations in the U.S. and many countries, MCFPA saw the need to build a new production line to meet this increasing demand.

MCFP began production of ALPOLIC® in Japan in 1971, and the Virginia plant opened in 1991. ALPOLIC® is known worldwide for its broad and innovative range of aluminum, stainless steel, titanium, galvanized steel and zinc composite products. They are a leading business for MCFP, which currently exports ALPOLIC® to more than 80 countries all over the world. MCFP’s head office is in Tokyo, Japan, with sales and marketing offices also in Singapore and Turkey, in addition to its United States operation. ALPOLIC® is also supported by a global business network with local agents and distributors worldwide.

ALPOLIC® has enjoyed a consistent increase in sales due to worldwide demand for the products across a wide variety of architectural applications. ALPOLIC® products are ideally suited for exterior and interior applications in high-rise buildings, airport terminals, factories, and other commercial and residential structures.

The overall production volume of ALPOLIC®, shared by the Chesapeake, Virginia plant and three plants in Japan, has reached a record high of 12 million square meters per annum. The expansion in Virginia makes it possible to ship ALPOLIC® from the United States to the European market with a shorter lead-time.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.